Seeking Alpha

Opko to list in Tel Aviv as part of Prolor purchase

  • Opko Health (OPK) plans to register its shares on the Tel Aviv Stock Exchange as part of its $540M acquisition of Israeli drugmaker Prolor Biotech.
  • The move, which will add to Opko's listing on the NYSE, will enable the company to pay for the purchase with locally listed stock.
  • Opko's shares will start trading on the TASE on Wednesday. In October, the stock will enter the Tel Aviv 25 index of bluechip shares. (PR)
Comments (1)
  • stockmarketchamp
    , contributor
    Comments (21) | Send Message
    opk has now doubled since its move from the american exchange to the new york exchange as i traders caused stock reversal on August 21st 2013........major mistake daytrading this stock....opk will show profit ist quarter of 2014......revenues will more than double in 2015 over heard it first here...TEVA.....and Dr. frost will merge opk......look for price to be 21 dollars plus......donot underestimate Dr. frost's connections in the global medical world....where he is much will be made...i cannot express these sentiments enough.....opk is a triple from here.....also....covered ryl at 35.....fdml...could become well as oww.....yelp building a base at 49-50.....look for upside soon
    22 Aug 2013, 09:11 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: